StockData
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31

BIOADAPTIVES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026

Market cap
$478.03K
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Bioadaptives's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Azuna Health LLC–100.00%13D (active)Apr 18, 2024
James Keener, Azuna Health LLC–100.00%13D (active)Apr 18, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Mark P. FrissoraDirector––Sep 3, 2026
Gimhana Sasanka DissanayakeDirector125,0000.06%Dec 3, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Gimhana Sasanka Dissanayake
Director
Nov 22, 2024Buy+125,000$0.09$11.25K125,000
Barry Epling
Director, 10% owner
Oct 1, 2013Buy+41,667$0.12$5.00K10,041,667
Holding Inc. Ferris
10% owner
Oct 1, 2013Buy+41,667$0.12$5.00K10,041,667
Richard Chiang
–
Jun 21, 2013Sale−10,000,000––0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.